Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
102.4 USD | -0.27% | -3.96% | +11.04% |
05-14 | Stephens Starts Blueprint Medicines With Overweight Rating, $140 Price Target | MT |
05-06 | Blueprint Medicines Insider Sold Shares Worth $1,050,000, According to a Recent SEC Filing | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BLUEPRINT MEDICINES CORPORATION | Other Biotechnology & Medical Research | -0.28% | -3.96% | +11.04% | +75.08% | +23.47% | 6.43B |
Technical Rankings Surperformance
- Stock Market
- Equities
- BPMC Stock
- Charts Blueprint Medicines Corporation
- Comparison Chart